drugset / Trial / NCT03571672

DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY

NCT03571672 ↗

Phase 3 Completed 153 enrolled Lantheus Medical Imaging Syneos Health · collab
NaSingle-groupOpen-labelDiagnostic

Summary

This is a Phase 3, prospective, open-label, multicenter study to evaluate Left Ventricular Ejection Fraction (LVEF) measurement accuracy and reproducibility of DEFINITY® contrast-enhanced and unenhanced echocardiography as compared with non-contrast cardiac magnetic resonance imaging (CMR) used as the truth standard.

Timeline

Start
2018-10-24
Primary completion
2019-08-30
Completion
2019-08-30

Outcome

Missed primary endpoint

registry analysis (superiority test); Blinded Reader 1; p = 0.868; Mean Difference (Final Values) -0.08; t-test, 2 sided NCT03571672 ↗

registry analysis (superiority test); Blinded Reader 2; p = 0.606; Mean Difference (Final Values) -0.23; t-test, 2 sided NCT03571672 ↗

registry analysis (superiority test); Blinded Reader 3; p = 0.224; Mean Difference (Final Values) -0.43; t-test, 2 sided NCT03571672 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Definity Diagnostic / imaging agent — —

Indications